Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03593226
Title Study to Evaluate Safety & Tolerability of AGI-134 in Solid Tumour
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Agalimmune Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR

Facility Status City State Zip Country Details
UCLA Los Angeles California 90095 United States Details
AHS Hospital Corp. Morristown New Jersey 07960 United States Details
Providence Cancer Institute Franz Clinic Portland Oregon 97213 United States Details
Emek Medical Center Afula 7177871 Israel Details
Rambam Health Care Campus Haifa 3109601 Israel Details
Hadassah Hebrew University Medical Center Jerusalem Israel Details
Sheba Medical Center Ramat Gan 52621 Israel Details
Tel Aviv Sourasky Medical Center Tel Aviv 6423906 Israel Details
University of Birmingham Birmingham B15 2TT United Kingdom Details
Edinburgh Cancer Research Centre Edinburgh EH4 2XR United Kingdom Details
The Beatson West of Scotland Cancer Centre Glasgow G12 0YN United Kingdom Details
University Collage London London W1T 7HA United Kingdom Details
The Christie NHS Foundation Trust Manchester M20 4BX United Kingdom Details
Churchill Hospital Oxford OX3 7LE United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field